Drugs, Prescription - As introduced, caps the total amount that a health insurance carrier can require a covered patient with diabetes to pay for a 30-day supply of insulin at no more than $100; caps the total price that a person who supplies prescription insulin drugs into or within this state for use by a patient with diabetes can charge for a 30-day supply of insulin at no more than $100. - Amends TCA Title 8; Title 53; Title 56, Chapter 7; Title 63 and Title 71, Chapter 5.
Bill status
in committee
1 of 4 stages cleared
Introduction
Jan 2020
Committee Review
Floor Vote
Governor
Introduced Jan 28, 2020
Last action Jun 1, 2020
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
15
Key actions
8
Committee
10
Jun 1, 2020
Lower · Passed
Taken off notice for cal. in Insurance Committee
lower
May 27, 2020
Lower · Passed
Placed on cal. Insurance Committee for 6/1/2020
lower
Mar 17, 2020
Upper · Passed
Action deferred in Senate Commerce & Labor Committee
upper
Mar 11, 2020
Lower · Passed
Rec. for pass by s/c ref. to Insurance Committee
lower
Mar 11, 2020
Lower · Passed
Placed on cal. Insurance Committee for 3/17/2020
lower
Mar 10, 2020
Upper · Passed
Placed on Senate Commerce and Labor Committee calendar for 3/17/2020
upper
Mar 4, 2020
Lower · Passed
Placed on s/c cal Life & Health Insurance Subcommittee for 3/11/2020
lower
Feb 3, 2020
Upper · Passed
Passed on Second Consideration, refer to Senate Commerce and Labor Committee
upper
Jan 31, 2020
Committee
Assigned to s/c Life & Health Insurance Subcommittee
lower
Jan 30, 2020
Committee
P2C, ref. to Insurance Committee
lower
Jan 30, 2020
Introduced
Introduced, Passed on First Consideration
upper
Jan 29, 2020
Introduced
Intro., P1C.
lower
2 primary · 0 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about SB 1939
Scope: TN
Hi! I can help you understand SB 1939. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline